A new chemotherapeutic agent: deoxycoformycin (pentostatin).
Dillman
R O
RO
Hoag Cancer Center, University of California, Irvine.
D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D015649:Pentostatin / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*
D058892:Adenosine Deaminase Inhibitors; D015649:Pentostatin